A detailed history of Advisor Net Financial, Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Advisor Net Financial, Inc holds 134 shares of BPMC stock, worth $12,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134
Previous 15 793.33%
Holding current value
$12,616
Previous $1,000 1100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$84.1 - $120.5 $10,007 - $14,339
119 Added 793.33%
134 $12,000
Q1 2024

Apr 12, 2024

BUY
$73.17 - $99.79 $1,097 - $1,496
15 New
15 $1,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.